WhitTier Trust Company’s Nu Skin NUS Stock Holding History

WhitTier Trust Company’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51	Closed	-$2.15K	–	1202
2022 Q4	$2.15K	Buy	+51	New	+$1.96K	﹤0.01%	1092

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

WhitTier Trust Company's NUS Position: Q1 2023 in Review

WhitTier Trust Company sold out of Nu Skin (NUS) in Q1 2023, closing a stake of 51 shares — an estimated $2.15K sold.

WhitTier Trust Company first reported a position in NUS in Q4 2022 and held it in 1 quarter. The position peaked at $2.15K in Q4 2022. 204 funds tracked by Wall St. Rank hold NUS as of Q1 2023.

WhitTier Trust Company reported no remaining Nu Skin position as of Q1 2023 after selling out during the quarter.
WhitTier Trust Company sold 51 Nu Skin shares in Q1 2023, an estimated $2.15K.
WhitTier Trust Company first reported a position in Nu Skin in Q4 2022 and held it in 1 quarter.
WhitTier Trust Company's Nu Skin position peaked at $2.15K in Q4 2022.
204 funds tracked by Wall St. Rank held Nu Skin as of Q1 2023.

Based on WhitTier Trust Company's 13F filing for Q1 2023, filed 21 Apr 2023.